Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 13 results

Author Title Type [ Year

]

Filters: Author is Logan, Brent [Clear All Filters]

2019

Ambinder, Richard F, Juan Wu, Brent Logan, Christine M Durand, Ryan Shields, Uday R Popat, Richard F Little, et al.. 2019. “Allogeneic Hematopoietic Cell Transplant For Hiv Patients With Hematologic Malignancies: The Bmt Ctn-0903/amc-080 Trial.”. Biol Blood Marrow Transplant 25 (11). Biol Blood Marrow Transplant: 2160-2166. doi:10.1016/j.bbmt.2019.06.033.

Pidala, Joseph, Michael Martens, Claudio Anasetti, Jeanette Carreras, Mary Horowitz, Stephanie J Lee, Joseph Antin, Corey Cutler, and Brent Logan. 2019. “Factors Associated With Successful Discontinuation Of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation.”. Jama Oncol. Jama Oncol. doi:10.1001/jamaoncol.2019.2974.

2018

Pasquini, Marcelo C, Brent Logan, Richard J Jones, Amin M Alousi, Frederick R Appelbaum, Javier Bolaños-Meade, Mary ED Flowers, et al.. 2018. “Blood And Marrow Transplant Clinical Trials Network Report On The Development Of Novel Endpoints And Selection Of Promising Approaches For Graft-Versus-Host Disease Prevention Trials.”. Biol Blood Marrow Transplant 24 (6). Biol Blood Marrow Transplant: 1274-1280. doi:10.1016/j.bbmt.2018.01.002.

2016

Lee, Stephanie J, Brent Logan, Peter Westervelt, Corey Cutler, Ann Woolfrey, Shakila P Khan, Edmund K Waller, et al.. 2016. “Comparison Of Patient-Reported Outcomes In 5-Year Survivors Who Received Bone Marrow Vs Peripheral Blood Unrelated Donor Transplantation: Long-Term Follow-Up Of A Randomized Clinical Trial.”. Jama Oncol 2 (12). Jama Oncol: 1583-1589. doi:10.1001/jamaoncol.2016.2520.

Laport, Ginna G, Juan Wu, Brent Logan, Veronika Bachanova, Chitra Hosing, Timothy Fenske, Walter Longo, et al.. 2016. “Reduced-Intensity Conditioning With Fludarabine, Cyclophosphamide, And High-Dose Rituximab For Allogeneic Hematopoietic Cell Transplantation For Follicular Lymphoma: A Phase Two Multicenter Trial From The Blood And Marrow Transplant Clinical Trials Networ”. Biol Blood Marrow Transplant 22 (8). Biol Blood Marrow Transplant: 1440-1448. doi:10.1016/j.bbmt.2016.04.014.

2014

Jacobsen, Paul B, Jennifer Le-Rademacher, Heather Jim, Karen Syrjala, John R Wingard, Brent Logan, Juan Wu, et al.. 2014. “Exercise And Stress Management Training Prior To Hematopoietic Cell Transplantation: Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn) 0902.”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1530-6. doi:10.1016/j.bbmt.2014.05.027.

Saber, Wael, Jennifer Le Rademacher, Mikkael Sekeres, Brent Logan, Moira Lewis, Adam Mendizabal, Eric Leifer, et al.. 2014. “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant To Hypomethylating Therapy Or Best Supportive Care In Patients Aged 50 To 75 With Intermediate-2 And High-Risk Myelodysplastic Syndrome: Blood And M”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1566-72. doi:10.1016/j.bbmt.2014.06.010.

Cutler, Corey, Brent Logan, Ryotaro Nakamura, Laura Johnston, Sung Choi, David Porter, William J Hogan, et al.. 2014. “Tacrolimus/sirolimus Vs Tacrolimus/methotrexate As Gvhd Prophylaxis After Matched, Related Donor Allogeneic Hct.”. Blood 124 (8). Blood: 1372-7. doi:10.1182/blood-2014-04-567164.

2012

Kamani, Naynesh R, Mark C Walters, Shelly Carter, Victor Aquino, Joel A Brochstein, Sonali Chaudhury, Mary Eapen, et al.. 2012. “Unrelated Donor Cord Blood Transplantation For Children With Severe Sickle Cell Disease: Results Of One Cohort From The Phase Ii Study From The Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn).”. Biol Blood Marrow Transplant 18 (8). Biol Blood Marrow Transplant: 1265-72. doi:10.1016/j.bbmt.2012.01.019.

2011

Krishnan, Amrita, Marcelo C Pasquini, Brent Logan, Edward A Stadtmauer, David H Vesole, Edwin Alyea, Joseph H Antin, et al.. 2011. “Autologous Haemopoietic Stem-Cell Transplantation Followed By Allogeneic Or Autologous Haemopoietic Stem-Cell Transplantation In Patients With Multiple Myeloma (Bmt Ctn 0102): A Phase 3 Biological Assignment Trial.”. Lancet Oncol 12 (13). Lancet Oncol: 1195-203. doi:10.1016/S1470-2045(11)70243-1.

2010

Levine, John E, Brent Logan, Juan Wu, Amin M Alousi, Vincent Ho, Javier Bolaños-Meade, and Daniel Weisdorf. 2010. “Graft-Versus-Host Disease Treatment: Predictors Of Survival.”. Biol Blood Marrow Transplant 16 (12). Biol Blood Marrow Transplant: 1693-9. doi:10.1016/j.bbmt.2010.05.019.

Jacobson, Pamala A, Jiayin Huang, Juan Wu, Miae Kim, Brent Logan, Amin Alousi, Michael Grimley, et al.. 2010. “Mycophenolate Pharmacokinetics And Association With Response To Acute Graft-Versus-Host Disease Treatment From The Blood And Marrow Transplant Clinical Trials Network.”. Biol Blood Marrow Transplant 16 (3). Biol Blood Marrow Transplant: 421-9. doi:10.1016/j.bbmt.2009.11.010.

2008

Logan, Brent, Eric Leifer, Chris Bredeson, Mary Horowitz, Marian Ewell, Shelly Carter, and Nancy Geller. 2008. “Use Of Biological Assignment In Hematopoietic Stem Cell Transplantation Clinical Trials.”. Clin Trials 5 (6). Clin Trials: 607-16. doi:10.1177/1740774508098326.